Thursday, November 20, 2008 - 3:29AM EST

General Interest Articles

11. Clinical outcomes three years after PLAATO implantation.

Author
El-Chami MF; Grow P; Eilen D; Lerakis S; Block PC;
Institution
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Journal
Catheter Cardiovasc Interv. 2007 Apr 1;69(5):704-7.
Abstract URL
Click here to view abstract

12. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials.

Author
Cleland JG; Shelton R; Nikitin N; Ford S; Frison L; Grind M;
Institution
Department of Cardiology, Kingston-upon-Hull, UK.
Journal
Eur J Heart Fail. 2007 Mar 12;.
Abstract URL
Click here to view abstract

13. Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation.

Author
Rao BH; Saksena S;
Institution
Electrophysiology Research Foundation, Warren, NJ, USA.
Journal
J Interv Card Electrophysiol. 2007 Mar 20;.
Abstract URL
Click here to view abstract

14. Prediction of conversion from paroxysmal to permanent atrial fibrillation.

Author
Budeus M; Felix O; Hennersdorf M; Wieneke H; Erbel R; Sack S;
Institution
Department of Cardiology, West-German Heart Centre, University of Duisburg-Essen, Essen, Germany. marco.budeus@uk-essen.de
Journal
Pacing Clin Electrophysiol. 2007 Feb;30(2):243-52.
Abstract URL
Click here to view abstract

15. Management of atrial fibrillation in patients with heart failure.

Author
Stevenson WG; Tedrow U;
Institution
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. wstevenson@partners.org
Journal
Heart Rhythm. 2007 Mar;4(3 Suppl):S28-30. Epub 2006 Dec 6.
Abstract URL
Click here to view abstract

16. Medical management of atrial fibrillation: future directions.

Author
Page RL;
Institution
Department of Internal Medicine (Cardiology Division), University of Washington School of Medicine, Seattle, Washington 98195-6422, USA. rpage@u.washington.edu
Journal
Heart Rhythm. 2007 Mar;4(3 Suppl):S91-4. Epub 2006 Dec 15.
Abstract URL
Click here to view abstract

17. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.

Author
Miyasaka Y; Barnes ME; Bailey KR; Cha SS; Gersh BJ; Seward JB; Tsang TS;
Institution
Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Journal
J Am Coll Cardiol. 2007 Mar 6;49(9):986-92. Epub 2007 Feb 16.
Abstract URL
Click here to view abstract

18. Operative and Percutaneous Procedures for Cure of Atrial Fibrillation.

Author
Thomas SP;
Institution
The Department of Cardiology, Westmead Hospital, Westmead, NSW 2145, Australia; The University of Sydney, NSW, Australia.
Journal
Heart Lung Circ. 2007 Apr 17;.
Abstract URL
Click here to view abstract

19. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.

Author
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Bocker D;
Institution
1 Department of Cardiology and Angiology, University Hospital Munster, D-48129 Munster, Germany.
Journal
Europace. 2007 Apr 17;.
Abstract URL
Click here to view abstract

20. Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation.

Author
Ruigomez A; Garcia Rodriguez LA; Johansson S; Wallander MA; Edvardsson N;
Institution
Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain. aruigomez@ceife.es
Journal
Clin Cardiol. 2007 Dec;30(12):624-8.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4